Skip to main content
. 2024 Mar 30;16(7):1370. doi: 10.3390/cancers16071370

Figure 2.

Figure 2

Expression of immune markers within the tumor of the immune-low HCC subtype. The images illustrate the immunostaining with monoclonal antibodies against CD3 (T cells), CD8 (CD8 T cells), CD20 (B cells), and alpha-SMA (stromal activation) in paraffin liver sections from six HBV-HCC patients with the immune-low subtype taken at the time of liver transplantation from the center of the tumor (area A) (200× magnification).